Scientific reports · 2017
Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Codoñer Francisco M, Peña Ruth, Blanch-Lombarte Oscar, Jimenez-Moyano Esther, Pino Maria, Vollbrecht Thomas, Clotet Bonaventura, Martinez-Picado Javier, Draenert Rika, Prado Julia G
Аннотация
Despite the major role of Gag in establishing resistance of HIV-1 to protease inhibitors (PIs), very limited data are available on the total contribution of Gag residues to resistance to PIs. To identify in detail Gag residues and structural interfaces associated with the development of HIV-1 resistance to PIs, we traced viral evolution under the pressure of PIs using Gag-protease single genome sequencing and coevolution analysis of protein sequences in 4 patients treated with PIs over a 9-year period. We identified a total of 38 Gag residues correlated with the protease, 32 of which were outside Gag cleavage sites. These residues were distributed in 23 Gag-protease groups of coevolution, with the viral matrix and the capsid represented in 87% and 52% of the groups. In addition, we uncovered the distribution of Gag correlated residues in specific protein surfaces of the inner face of the viral matrix and at the Cyclophilin A binding loop of the capsid. In summary, our findings suggest a tight interdependency between Gag structural proteins and the protease during the development of resistance of HIV-1 to PIs.
Предметные рубрики MeSH
Amino Acid SubstitutionCD8-Positive T-LymphocytesCapsidDrug Resistance, ViralEvolution, MolecularHIV InfectionsHIV ProteaseHIV Protease InhibitorsHIV-1HumansModels, MolecularPhylogenyProtein ConformationSelection, GeneticStructure-Activity RelationshipViral Matrix Proteinsgag Gene Products, Human Immunodeficiency Virus